#Coronavirus Testing Kit in India

[pathologylab]

Stay informed and vigilant about the recent upsurge in the #COVID-19 cases in India due to the new JN.1 variant. Get quick and accurate results with #G2M’s #COVID19 rapid antigen test kit! With 98% accuracy and results in just 10 minutes, you can take control of your #health from the comfort of your own home. Stay safe and stay informed with our easy-to-use #testing solution.

#ORDER NOW!!! https://www.covieasy.com/

For more details, Call us at +91-8800821778 or drop us an email at social@genes2me.com

#genes2me #rapid #rapidtest #selftestrevolution #coronavirus #testing #kit #solutions #antigen #antibody #diagnosis #madeinindia #india

[bills-bible-basics]

Coronavirus: Latest Statistics on Bill's Bible Basics Blog https://www.billkochman.com/Blog/index.php/coronavirus-latest-statistics-bills-bible-basics-blog/ NOTE: Be advised that due to the ongoing situation regarding the global coronavirus (COVID-19) pandemic, this blog post will be updated frequently, as my time permits, until world health officials determine that the virus has peaked, and is on a steady downward trend worldwide. CORONAVIRUS LATEST STATISTICS Last Updated On: Saturday, February 27, 2021 Last Updated At: 01:24 PM ChST (Chamorro Standard Time/GMT+10) Total Countries Infected: 192 Please note that the accuracy of the figures which are shared in this BBB Blog post is based on two things: 1. The honesty and accuracy of the governments and health institutions which are reporting these statistics. 2. The level of testing which is being conducted by each nation which contributes statistics to this list. Having said that, because some nations have been very slow to conduct tests, and/or have a very limited number of test kits in their possession, it is most probable that the figures listed below are far below reality. In short, the more tests each nation conducts, the more accurate these statistics will become over time. However, they will never be completely accurate due to a variety of reasons, which I explain in my series "Coronavirus: Just the Facts, Ma'am", as well as in other BBB Blog posts. Nations With 1000+ Confirmed Cases: Note: To see a complete list, please go to https://www.billkochman.com/covid-19.html Country Confirmed Active Deaths Recovered Total 113,375,335 46,932,969 2,515,896 63,926,470 USA 28,484,429 27,974,106 510,323 None India 11,063,491 155,986 156,825 10,750,680 Brazil 10,455,630 922,787 252,835 9,280,008 Russia 4,175,757 350,799 83,900 3,741,058 United Kingdom 4,175,315 4,041,088 122,648 11,579 France 3,746,707 3,399,320 85,738 261,649 Spain 3,188,553 2,969,035 69,142 150,376 Italy 2,888,923 404,664 97,227 2,387,032 Turkey 2,683,971 98,754 28,432 2,556,785 Germany 2,436,506 126,155 69,750 2,240,601 Colombia 2,244,792 43,400 59,518 2,141,874 Argentina 2,098,728 154,007 51,887 1,892,834 Mexico 2,069,370 265,670 183,692 1,620,008 Poland 1,684,788 235,883 43,353 1,405,552 Iran 1,615,184 175,363 59,899 1,379,922 South Africa 1,510,778 34,577 49,784 1,426,417 Ukraine 1,381,273 148,244 27,146 1,205,883 Indonesia 1,322,866 158,408 35,786 1,128,672 Peru 1,308,722 52,070 45,903 1,210,749 Czechia 1,212,780 137,698 19,999 1,055,083 Netherlands 1,093,899 1,063,943 15,626 14,330 Canada 866,735 30,261 21,915 814,559 Chile 816,929 23,578 20,400 772,951 Portugal 802,773 72,037 16,243 714,493 Romania 795,732 39,479 20,233 736,020 Israel 770,780 39,356 5,697 725,727 Belgium 763,885 741,879 22,006 None Iraq 688,698 45,155 13,365 630,178 Sweden 657,309 644,483 12,826 None Pakistan 577,482 22,285 12,804 542,393 Philippines 571,327 34,498 12,247 524,582 Switzerland 554,932 227,371 9,961 317,600 Bangladesh 545,424 41,531 8,395 495,498 Morocco 482,994 5,999 8,608 468,387 Austria 454,860 19,088 8,515 427,257 Serbia 453,240 448,826 4,414 None Japan 429,860 15,614 7,818 406,428 Hungary 419,182 86,488 14,795 317,899 United Arab Emirates 385,160 6,425 1,198 377,537 Jordan 383,912 35,422 4,650 343,840 Saudi Arabia 376,723 2,549 6,483 367,691 Lebanon 369,692 80,032 4,610 285,050 Panama 339,781 9,125 5,820 324,836 Slovakia 303,420 41,154 6,966 255,300 Malaysia 295,951 27,994 1,111 266,846 Belarus 284,500 7,800 1,957 274,743 Ecuador 282,599 28,069 15,713 238,817 Nepal 273,984 936 2,771 270,277 Georgia 270,137 2,605 3,485 264,047 Kazakhstan 260,384 20,470 3,160 236,754 Bolivia 246,822 44,164 11,577 191,081 Bulgaria 245,627 32,005 10,128 203,494 Croatia 242,097 3,046 5,503 233,548 Dominican Republic 238,205 45,960 3,082 189,163 Azerbaijan 233,989 2,297 3,213 228,479 Tunisia 231,964 27,077 7,942 196,945 Ireland 218,251 190,587 4,300 23,364 Denmark 210,900

6,328 2,354 202,218 Costa Rica 204,341 24,442 2,800 177,099 Lithuania 196,690 11,202 3,225 182,263 Kuwait 189,046 10,841 1,072 177,133 Slovenia 188,676 12,948 3,823 171,905 Greece 188,201 87,998 6,439 93,764 Moldova 183,338 14,551 3,899 164,888 Egypt 181,241 30,724 10,590 139,927 West Bank and Gaza 180,848 13,624 2,019 165,205 Guatemala 173,814 6,890 6,348 160,576 Armenia 171,510 5,162 3,183 163,165 Honduras 168,243 98,719 4,099 65,425 Qatar 162,737 9,673 257 152,807 Paraguay 157,603 22,990 3,152 131,461 Ethiopia 157,047 20,146 2,340 134,561 Nigeria 155,076 20,630 1,902 132,544 Burma 141,875 7,242 3,198 131,435 Oman 140,588 7,342 1,562 131,684 Venezuela 138,295 6,578 1,338 130,379 Libya 132,458 10,792 2,174 119,492 Bosnia and Herzegovina 130,979 10,061 5,071 115,847 Bahrain 121,127 6,886 442 113,799 Algeria 112,805 31,986 2,977 77,842 Kenya 105,467 17,093 1,853 86,521 Albania 105,229 35,466 1,756 68,007 North Macedonia 101,762 7,748 3,119 90,895 China 100,885 490 4,834 95,561 Korea, South 89,321 7,393 1,595 80,333 Kyrgyzstan 86,142 1,618 1,463 83,061 Latvia 84,983 9,304 1,601 74,078 Ghana 82,586 5,419 594 76,573 Sri Lanka 82,430 4,346 459 77,625 Uzbekistan 79,804 849 622 78,333 Zambia 77,639 3,938 1,066 72,635 Montenegro 74,789 8,544 994 65,251 Norway 70,564 51,944 622 17,998 Kosovo 68,451 7,419 1,592 59,440 Estonia 62,830 13,764 575 48,491 Singapore 59,913 81 29 59,803 El Salvador 59,866 2,713 1,841 55,312 Mozambique 58,218 17,799 613 39,806 Uruguay 56,542 6,929 601 49,012 Finland 56,407 15,665 742 40,000 Afghanistan 55,696 3,969 2,442 49,285 Luxembourg 55,110 2,986 637 51,487 Cuba 48,441 4,392 314 43,735 Uganda 40,322 25,372 334 14,616 Namibia 38,424 2,012 418 35,994 Zimbabwe 36,044 2,042 1,463 32,539 Cameroon 35,714 2,569 551 32,594 Cyprus 34,181 31,893 231 2,057 Senegal 34,031 4,797 857 28,377 Cote d'Ivoire 32,478 857 190 31,431 Malawi 31,675 12,455 1,037 18,183 Sudan 30,284 5,543 1,878 22,863 Australia 28,965 5,154 909 22,902 Botswana 28,371 4,817 310 23,244 Thailand 25,809 774 83 24,952 Congo (Kinshasa) 25,691 6,698 707 18,286 Jamaica 22,471 8,827 413 13,231 Malta 21,982 2,582 313 19,087 Angola 20,759 948 504 19,307 Madagascar 19,831 238 297 19,296 Maldives 19,479 2,417 60 17,002 Rwanda 18,689 1,129 258 17,302 Mauritania 17,187 214 439 16,534 Eswatini 16,972 2,081 650 14,241 Guinea 15,894 926 89 14,879 Syria 15,467 4,812 1,018 9,637 Cabo Verde 15,253 353 146 14,754 Gabon 14,564 1,338 83 13,143 Tajikistan 13,308 0 90 13,218 Haiti 12,352 2,426 247 9,679 Belize 12,293 142 315 11,836 Burkina Faso 11,939 393 142 11,404 Andorra 10,822 318 110 10,394 Lesotho 10,491 6,454 292 3,745 Suriname 8,913 352 170 8,391 Congo (Brazzaville) 8,820 1,673 128 7,019 Bahamas 8,519 1,031 179 7,309 Guyana 8,513 373 195 7,945 Mali 8,358 1,653 350 6,355 Trinidad and Tobago 7,704 120 139 7,445 South Sudan 7,597 3,400 90 4,107 Togo 6,730 1,126 82 5,522 Somalia 6,687 2,680 223 3,784 Nicaragua 6,445 2,047 173 4,225 Djibouti 6,062 105 63 5,894 Iceland 6,049 14 29 6,006 Equatorial Guinea 5,957 261 91 5,605 Benin 5,434 1,116 70 4,248 Central African Republic 5,004 21 63 4,920 Niger 4,740 318 172 4,250 Gambia 4,691 454 148 4,089 Chad 3,957 369 138 3,450 Sierra Leone 3,884 1,193 79 2,612 San Marino 3,671 374 73 3,224 Comoros 3,558 159 144 3,255 Saint Lucia 3,356 409 35 2,912 Guinea-Bissau 3,241 596 48 2,597 Barbados 2,994 691 33 2,270 Eritrea 2,847 587 7 2,253 Mongolia 2,831 679 2 2,150 Seychelles 2,592 318 11 2,263 Liechtenstein 2,564 26 54 2,484 Vietnam 2,426 552 35 1,839 New Zealand 2,372 66 26 2,280 Yemen 2,267 206 627 1,434 Burundi 2,143 1,367 3 773 Liberia 2,010 41 85 1,884 Monaco 1,942 227 23 1,692 Sao Tome and Principe 1,745 381 28 1,336 Saint Vincent and the Grenadines 1,519 665 6 848 Papua New Guinea 1,228 370 12 846 For those of you who may have possibly missed some of my previous coronavirus-related writings, following is a list of everything I have written to date regarding the COVID-19 pandemic.

I believe that you will find a lot of useful, factual, instructive and Scriptural information in this material. Please feel free to share this list on your own timelines, pages, in your Facebook groups, and on any other social networks where you happen to participate. Thank you so very much, and God bless you! Bill's Bible Basics Coronavirus Information Center: Bill's Bible Basics Coronavirus Information Center Bill's Bible Basics Articles: BBB Article: "Coronavirus: Just the Facts, Ma'am": https://www.billkochman.com/Articles/coronavirus-1.html BBB Article: "COVID-19, Financial Assistance and Christian Love": https://www.billkochman.com/Articles/covid-19-financial-assistance-christian-love-1.html BBB Article: "Coronavirus: Defiant Christians, Stay Home!": https://www.billkochman.com/Articles/coronavirus-defiant-christians-stay-home-1.html BBB Article: "COVID-19: Exposure Logging and Contact Tracing: Is It Safe?": https://www.billkochman.com/Articles/COVID-19-ExposureLogging-ContactTracing-1.html Bill's Bible Basics Blog Posts: BBB Blog Post: "Coronavirus: Latest Statistics - Bill's Bible Basics Blog": https://www.billkochman.com/Blog/index.php/coronavirus-latest-statistics-bills-bible-basics-blog/ BBB Blog Post: "Stop Joking About the Coronavirus": https://www.billkochman.com/Blog/index.php/stop-joking-about-the-coronavirus/ BBB Blog Post: "Coronavirus: God Will Silence the Fools": https://www.billkochman.com/Blog/index.php/coronavirus-god-will-silence-the-fools/ BBB Blog Post: "Coronavirus: Be Still and Know That I Am God": https://www.billkochman.com/Blog/index.php/coronavirus-be-still-and-know-that-i-am-god/ BBB Blog Post: "Is COVID-19 the New Normal? : Don't Freak Out! Trust the Lord!": https://www.billkochman.com/Blog/index.php/is-covid-19-the-new-normal-dont-freak-out-trust-the-lord/ BBB Blog Post: "Helpful Tips Regarding Using Face Masks and Respirators": https://www.billkochman.com/Blog/index.php/helpful-tips-regarding-using-face-masks-and-respirators/ BBB Blog Post: "Coronavirus: Why Do You Condemn Your Brethren?": https://www.billkochman.com/Blog/index.php/coronavirus-coronavirus-why-do-you-condemn-your-brethren/ BBB Blog Post: "Coronavirus: Are You Distracted?": https://www.billkochman.com/Blog/index.php/coronavirus-are-you-distracted/ BBB Blog Post: "Coronavirus: Wake Up, Already!": https://www.billkochman.com/Blog/index.php/coronavirus-wake-up-already/ BBB Blog Post: "Coronavirus: 40 Bible Verse Lists Regarding God's Love, Patience, Wrath, Judgments and Repentance": https://www.billkochman.com/Blog/index.php/coronavirus-40-bible-verse-lists-regarding-gods-love-patience-wrath-judgments-and-repentance/ BBB Blog Post: "Coronavirus: Where is Your Common Sense?": https://www.billkochman.com/Blog/index.php/coronavirus-where-is-your-common-sense/ BBB Blog Post: "Coronavirus: More Useful Information": https://www.billkochman.com/Blog/index.php/coronavirus-more-useful-information/ BBB Blog Post: "The Doctor Anthony Fauci Debate: My View": https://www.billkochman.com/Blog/index.php/the-doctor-anthony-fauci-debate-my-view/ BBB Blog Post: "Coronavirus: How to Respond to the Pandemic": https://www.billkochman.com/Blog/index.php/coronavirus-how-to-respond-to-the-pandemic/ BBB Blog Post: "Coronavirus: Face Masks or Bandanas?": https://www.billkochman.com/Blog/index.php/coronavirus-face-masks-or-bandanas/ BBB Blog Post: "Coronavirus and Beards and Mustaches": https://www.billkochman.com/Blog/index.php/coronavirus-and-beards-and-mustaches/ BBB Blog Post: "Coronavirus: Do You Need A Psychiatric Evaluation?": https://www.billkochman.com/Blog/index.php/coronavirus-do-you-need-a-psychiatric-evaluation/ BBB Blog Post: "COVID-19: Attention iOS Users! This May Be of Interest to You if You Use the "Maps" App!": https://www.billkochman.com/Blog/index.php/covid-19-attention-ios-users-this-may-be-of-interest-to-you-if-you-use-the-maps-app/ BBB Blog Post: "Apple iOS 13.7 Introduces COVID-19 Exposure Notifications With No Need For 3rd Party App":

https://www.billkochman.com/Blog/index.php/apple-ios-13-7-introduces-covid-19-exposure-notifications-with-no-need-for-3rd-party-app/ BBB Blog Post: "Coronavirus: Are Vaccine Passports Inevitable?": https://www.billkochman.com/Blog/index.php/coronavirus-are-vaccine-passports-inevitable/ BBB Blog Post: "Coronavirus: Don't Be So Harsh!": https://www.billkochman.com/Blog/index.php/coronavirus-coronavirus-dont-be-so-harsh/ Bill's Bible Basics Poetry: BBB Poem: "Coronavirus Kooks": https://www.billkochman.com/Poetry/coronavirus-kooks.html https://www.billkochman.com/Blog/index.php/coronavirus-latest-statistics-on-bills-bible-basics-blog/?feed_id=79356&_unique_id=6514f13eed747&Coronavirus%3A%20Latest%20Statistics%20on%20Bill%27s%20Bible%20Basics%20Blog

[screenshots123]

📆 11 Sep 2023 📰 Covid infections skyrocket in Spain and Europe 🗞 Murcia Today

A study carried out by consultancy firm IQVIA on 6,500 pharmacies across Spain has revealed that the sale of antigen tests to detect Covid-19 has increased by 556% between August 28 and September 3 compared to the last week in June. During this small stretch, more than half a million tests were sold, coinciding with a substantial rise in the number of hospitalisations due to coronavirus.

Here in Spain, the sale of antigen tests has increased the most in Extremadura in the last week (+1,374%), followed by Castilla- La Mancha (+1,265%), Castilla y Leon (+991%) and the Valencian Community (+848%).

The Canary Islands are faring the best, but the number of Covid home-testing kits purchased has still risen by 91%.

Spain's president Pedro Sánchez has become the latest big name to succumb to coronavirus, testing positive on Thursday September 7. As a result of the diagnosis, Mr Sánchez has been forced to cancel his appearance at the G20 Summit scheduled to take place in India.

[kritikapatil]

Coronavirus Diagnostics Market to Scale New Heights as Market Players Focus on Innovations 2022 – 2027

Latest added Coronavirus Diagnostics Market research study by AMA Research offers detailed outlook and elaborates market review till 2027. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are

F. Hoffmann-La Roche AG (Switzerland)

Bio-Rad Laboratories Inc. (United States)

Beckman Coulter Inc. (United States)

Becton, Dickinson, and Company (United States)

Lonza Group AG (Switzerland)

Hologic, Inc. (United States)

QIAGEN (Germany)

GlaxoSmithKline Biologicals SA (Belgium)

Abbott Laboratories (United States)

Perkin Elmer, Inc. (United States)

Neuberg Diagnostics (India)

1drop Inc. (Switzerland)

Veredus Laboratories (Hong Kong)

ADT Biotech (Malaysia)

Quest Diagnostics (United States)

LabCorp (United States)

altona Diagnostics GmbH (Germany)

bioMérieux SA (France)

Mylab Discovery Solutions Pvt Ltd. (India)

Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 represents the virus's membership of the coronavirus family, with its first human interaction noted in 2019. Coronavirus is the term coined for the family of viruses that are transmitted between animals and humans. Hence they are also known as zoonotic viruses. In addition, the virus outbreak was confirmed on March 27, 2020, on six continents and in more than 197 countries. According to the World Health Organization (WHO), fever, fatigue and dry cough are common symptoms of Covid-19 infection. Other symptoms of the disease include shortness of breath, sore throat, pain, and diarrhea in some cases, as well as nausea or a runny nose. In addition, this infection can spread from one person to another through droplets of saliva, or it can leak out of the nose when an infected person coughs or sneezes. The time from a person's exposure to Covid-19 to the onset of symptoms is generally between two and fourteen days, with an average of five days. The current status of lead COVID testing is toward increasing capacity but mixed accuracy. For efficient and accurate COVID-19 diagnosis, doctors need a portable or on-site diagnostic test to be able to manage patients in real-time in the shortest possible time. This has encouraged the introduction of point-of-care (POC) tests for diagnosis, the primary aim of which is to cut test times from hours to minutes. The most common concern of the governments of all nations affected by Covid-19 is the intolerable need to screen and test large numbers of patients for possible Sars-Cov-2 infections. As a result, most of them face significant bottlenecks in the supply of diagnostic kits to test for the virus. Diagnostic virology companies have been under immense pressure so as to provide reliable test kits and also the demand for the in vitro or point-of-care testing capabilities in the laboratories in various countries is also increasing. However, with the introduction of automated SARS-CoV-2 test systems, the diagnosis increases its capacity to carry out such tests considerably. However, currently, only a few companies are focused on developing rapid immunoassay tests for Covid-19 diagnosis.

Influencing Trend: A Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing

An Upsurge in Validating and Developing Rapid POC Immunodiagnostic Tests to Facilitate Decentralized Testing

Growing Trend of Incorporation of Artificial Intelligence (AI) in the COVID-19 Tests for Rapid and Efficient Diagnosis

Challenges: Shortage of Medical Professionals That Have Sufficient Knowledge Regarding the Use of Diagnostic Kits for COVID-19

Opportunities: Growth in Funding For Research on Coronavirus Diagnostics

Increasing Application of Molecular Diagnostic Technologies in Pharmacogenetics and Point-Of-Care Testing

The Rise in Integration of Novel Technologies and Software Solutions with COVID-19 Testing

Market Growth Drivers: The Increasing Global Prevalence of COVID-19

Unavailability of Specific Medicine or a Vaccine for the Coronavirus Disease

An Increase in the Need for Developing Diagnostic Tests Owing to the Global Conditions

The Increased Demand for Rapid Immunoassay Tests for Disease Diagnosis

The Global Coronavirus Diagnostics segments and Market Data Break Down by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV), End-Users (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Diagnostic Centers and Clinics, Research Institutes, Others), Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab), Mode of Diagnosis (Point-of-Care (POC), Non-Point-of-Care (Non-PoC))

Presented By

AMA Research & Media LLP

[impossibledeanmakerwombat]

Virology Specimen Collection Market: Worldwide Industry Analysis and New Market Opportunities Explored to 2032

According to a recent virology specimen collection market report by Future Market Insights (FMI), the motor monitoring market is anticipated to advance at a phenomenal CAGR of -0.5% over the forecast period 2022-2032. The market for virology specimen collection was valued at US$ 5.6 billion globally in 2021, and it is anticipated to grow at a negative CAGR of -0.5% from 2022 to 2032.

Additionally, the rising prevalence of viral infections like SARS-CoV-2, AIDS, flu, EBOLA, Zika virus, and STDs boosts the demand for virology specimen collection.

The Zika virus and Babesia outbreaks, alongside announcements for their inclusion in virology specimen collection tests, indicate the need for innovation in virology specimen collection technologies, consumables, laboratory testing and instruments. Other countries have also undertaken initiatives to check for new and emerging diseases.

 Request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14266

The high cost of technologies and collection kits and usage of flow sensitivity screening are the major factors hampering the growth of the virology specimen collection market.

Some emerging markets such as India, the Middle East, and Africa offer promising virology specimen collection opportunities for players in the industry due to their increasing disposable incomes and improving healthcare infrastructure.

The comparatively high cost of laboratory testing has boosted the increasing use of older and less practical tests, for example, first-generation ELISA.

The test has been used in various parts of the world despite its limitation.

The high costs of the virology specimen collection products serve as the critical factor curtailing the growth impetus in the market.

There is a crucial requirement to reduce the costs of these products to create demand for virology specimen collection. Otherwise, it is estimated to hinder the virology specimen collection growth even in upcoming years.

During the diagnostics investigations, different microbiology specimen collection mediums are recommended to stabilize specimens for the detection of viruses and bacteria.

Thus, based on these factors, the virology swab sample market is likely to experience innumerable growth avenues in the forthcoming years.

It is expected to have a digital future of public health, and there comes a crucial requirement to align the international strategies for evaluation and regulation.

There is high competition among the virology specimen collection market players.

Only major companies can afford high-capital investments and the cost of R&D and manufacturing. That prevents new entrants from entering the virology specimen collection market.

Key Takeaways:

North America is anticipated to be at the forefront of the virology specimen collection market future trends, which can be attributed to the increasing adoption of NAT and technological advancements such as portable diagnostics.

The bacterial specimen collection segment is projected to lead the virology collection market trend by product type. The high prevalence of tuberculosis (TB) is one of the significant factors contributing to the share of the segment.

Diagnostic applications are expected to account for a significant portion of the virology specimen collection market size due to a spike in the number of FDA-approved specimen collection kits, transport of viral specimen, and virology swab sample for clinical applications.

By end use, the hospitals and clinics segment is anticipated to generate the most revenue, owing to an uptick in patients with respiratory viruses and bacterial infections.

The Asia Pacific market for bacterial and virology sample collection is expected to grow at a rapid pace because of extensive coronavirus testing in Asian countries.

By technology, the segment of the nasopharyngeal sample is estimated to hold sway on account of rapid detection of transmissible transfusion infections (TTIs) and the rising prevalence of HPV-related cancers and human papillomavirus (HPV).

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-14266

“Virology specimen collection tests emphasize the need for virology specimen collection technology innovation and adoption, consumables, and instruments. This is projected to drive the demand for the virology specimen collection market further.” opines an FMI analyst.

Competitive Landscape:

A few notable virology specimen collection market players include Puritan Medical Products Co. (UK), Trinity Biotech (Ireland), Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Vircell S.L. (Spain), Becton, Quidel Corporation (US), Titan Biotech Ltd. (India), Diasorin SA (Italy), Copan Italia S.P.A (Italy), Hardy Diagnostics (US).

These firms and companies are partnering & collaborating with several domestic and international players as a part of the emerging trends in the viral specimen collection market.

Henkel AG & Co. KGaA of Germany tied up with Origin of California to leverage the latter’s expertise in performing robust mechanical testing at its California facility. Henkel also contributed expertise and technology to developing 3D printed nasopharyngeal swabs for COVID-19 testing and several other recent developments in the virology specimen collection market.

Under a USD 6.0 million contract with Inflammatix Inc., the US HHS supported the development of the host-response testing technology. The company is working on three diagnostic tests that will provide quick results on whether the infection is bacterial or viral. This enables clinicians to make better-informed, earlier treatment decisions. Such initiatives are also at the heart of the companies’ strategy to expand earlier diagnosis.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14266

Key Segments By Product Type:

Blood Collection Kits

Specimen Collection Tubes

Viral Transport Media

Swabs

By Sample:

Blood Samples

Nasopharyngeal Samples

Throat Samples

Nasal Samples

Cervical Samples

Oral Samples

Other Samples

[imaec-digital]

How long to wear PPE kit?

Personal Protective Equipment (PPE) for Infection Control:

Personal Protective Equipment (PPE) is specialised clothing or equipment that employees wear to protect themselves from infectious materials. By forming a barrier between the potential infectious material and the health care worker, PPE prevents contact with an infectious agent or body fluid that may contain an infectious agent.

Components of Personal Protective Equipment (PPE):

Specific PPE component information. Gloves, gowns, shoe covers, head covers, masks, respirators, eye protection, face shields, and goggles are all examples of protective clothing.

• Gloves: Gloves protect you when you are in direct contact with potentially infectious materials or contaminated surfaces.

• Gowns: Gowns protect you from potentially infectious material contaminating your clothing.

• Shoe and head cover: Shoe and head covers protect against possible contamination in a contaminated environment.

• Surgical masks and respirators protect your nose and mouth from splattered body fluids, while respirators filter the air before you inhale it.

• Other Face and Eye Protection: Goggles shield your eyes only from splatters. A face shield protects the skin, eyes, nose, and mouth from splatter.

Making Disposable Personal Protective Equipment Kits:

Gather your supplies to create your own PPE kit. A disposable PPE kit should include the following items:

• One disposable gown,

• One pair of gloves,

• face shield,

• hair and shoe covers,

• and a red bag

Standards and Specifications for Gowns:

ANSI/AAMI PB70 – Liquid barrier performance and classification of protective apparel and drapes intended for use in healthcare facilities. – Applies to surgical gowns and isolation gowns

2. EN 13795 – Surgical drapes, gowns, and clean air suits, used as medical devices for patients, clinical staff, and equipment. General requirements for manufacturers, processors and products, test methods, performance requirements and performance levels. – Applies to surgical gowns

3. ASTM F2407- Standard specification for surgical gowns intended for use in healthcare facilities – Applies to surgical gowns

Difficulties Faced When Using PPE Kits and How to Overcome Them:

• Background:

Following a slow start due to an effective lockdown, India’s coronavirus disease 2019 (COVID-19) pandemic has been raging at a rapid pace, posing a formidable challenge to the country’s healthcare system. Personal protective equipment (PPE) unquestionably provides a shield of protection for healthcare workers (HCWs) combating disease as a valuable asset to the nation. However, there have been a number of issues with the PPE, ranging from a lack of it to problems caused by heat, dehydration, and other factors while wearing it. There is a need to assess these issues faced by HCWs both qualitatively and quantitatively in order to address them in a timely and effective manner.

• Methods:

An electronic questionnaire survey was administered to a group of HCWs who had performed COVID-19 duties and used PPE kits. The cohort included various types of doctors, nurses, and other paramedical personnel.

• Results:

Excessive sweating (100%), fogging of goggles, spectacles, or face shields (88%), suffocation (83%), breathlessness (61%), fatigue (75%), headache due to prolonged use (28%), and pressure marks on the skin at one or more areas on repeated use were the most common problems associated with using PPE kits (19 percent ). Skin allergy/dermatitis caused by the synthetic material of the PPE kit, face shield impinging on the neck during intubation, nasal pain, pain at the root of the pinna, and slipperiness of shoe covers were all reported on occasion. HCWs have used a variety of methods and means to address and solve these issues.

• Conclusion:

These plausible solutions will undoubtedly assist HCWs in dealing with and resolving problems associated with PPE use.

Distribution of the number of PPE kits used per duty among various classes of HCWs:

As per survey it is discovered that 101 (40%) of respondents had completed more than 28 days of COVID duty, 83 (33%) had completed 7-14 days, 49 (19%) had completed 15-28 days, and 20 HCWs (8%) had completed up to seven days of COVID duty at the time of survey submission. The median period of completed duty was 15-28 days (IQR=7-14 days). In terms of duty hours per day, 131 respondents (52%) had done 8-12 hours per day, 48 (19%) had done 12 hours or more, 44 (17%) had done six to eight hours, and 30 (12%) had done up to six hours of COVID duty per day.

Excessive sweating (100 percent), fogging of goggles, spectacles, or face shields (88 percent, suffocation (83 percent), breathlessness (61 percent), fatigue (75 percent), headache due to prolonged use (28 percent), and pressure marks on the skin at one or more areas on repeated use were the most common problems associated with using PPE kits (19 percent ). India is a tropical country with hot and, at times, humid weather. As a result, this problem seemed even more daunting. To prevent the spread of droplets and droplet nuclei, hospitals’ central air conditioning systems (with common air duct systems) were turned off. On continuous use, symptoms of dehydration such as muscle cramps, dizziness, vertigo, and nausea were also reported.

One respondent actually collapsed and had to be hospitalised due to symptoms similar to heatstroke. Similar reports from other centres are not uncommon. Respondents reported drinking moderate amounts of cool water before donning (74%), changing kits frequently with intervals in between (59%) and using an AC relaxation room (7%) to alleviate dehydration. Exhaust fans were also installed in each patient room and ICU by the health administration. By creating a negative pressure environment, this not only helped with heat reduction but also reduced the risk of suspended droplets in a closed space. Other researchers have supported similar strategies in the form of pre-cooling (drinking ice slurry), per-cooling (cooling vests)

[rakeshbhairajdev]

Special Aid Offered By Rakesh Rajdev To The Society

1.Food distribution – During the coronavirus spread, food scarcity reached a new height. Hence Rakesh Rajdev took several steps to offer a helping hand to all the survivors with his social welfare organization. He ensured the distributionof food to various regions in India. A large number of meal boxes reached the hands of the sufferers. He ensured to send all these through 34 trains so that it will their hometown.

2.Medical assistance – With the spread of the COVID-19 virus, the hospitals and medical centres were jammed with patients. To help them cope with the situation, Rakesh Bhai Rajdev offered beds, testing kits, sanitizing materials and other necessary medical equipment so that they can continue offering treatment to the patients.

3.Educational aid – Students are the future of the nation. But Rakesh Bhai Rajdev felt sad since the children’s family suffer from poverty and discontinued their children’s education. To offer educational aid to them, Rakesh provided school bags, lunch boxes, water bottles, notebooks and other necessary stationery items. For the deserving students, Rakesh Rajdev offered food packages so that they will not suffer from hunger issues.

4.Grocery package distribution – As the government imposed lockdown, a large number of families lost their jobs. Especially labourers and daily wagers were affected a lot. Hence, Rakesh Bhai Rajdev offered financial assistance to the suffering people’s families and people. He offered grocery packages and sanitizing materials through his social welfare organization namely KanudaMitra Mandal to a large number of families.

5.Financial help for refugees – Refugees faced a lot of challenges during this time. Many people also got stuck in their working place during the lock down. Hence Rakesh Rajdev ensured to arrange a transportation option so that they can reach their hometown safely.

Follow Us On Our Social Media Pages

Facebook, Instagram, YouTube

[haledhometest]

Are COVID-19 Test Kits for Home Use Really Effective?

The use of Covid-19 home-test kits everywhere has increased as cases of the new variety of Covid-19, omicron, begin to recur. According to recommendations, symptomatic people and close relatives of confirmed cases can utilize the self-use test from the proximity of their home. Users of this test won't require a healthcare professional to take a sample as it can be done by the patient himself. This reduces testing delays and relieves pressure on overworked labs. Experts advise that these tests be performed prudently and in lieu of the aforementioned COVID-19 requirements. A rise in Covid-19 cases is being attributed to the Omicron version of the coronavirus, especially in China, which is why self-test kits are extensively utilized in many Western and Eastern nations. On the other hand, the usage of self-test kits has so far been restrained in some countries and only lab tests are performed.

However, data compiled from multiple manufacturers and pharmaceutical portals suggests that sales of home covid 19 test kits climbed in India in December as cases started to rise again, albeit not as substantially as in other nations. These kits, according to experts, are a good tool for widespread Covid-19 screening because they offer cheaper results quickly. Before the epidemic, self-testing everywhere was mostly used to confirm pregnancies and monitor blood sugar levels. In India, a self-test for a disease is now accessible for the first time. "The main objective of self-test is to immediately discover and isolate an infected person," according to a reputed doctor. If they don't want to go to a lab, people who have been exposed to an infected individual or have symptoms ought to do this test, he advised. So, which test should you take?

Results from a  Covid-19 antibody test kit are available in about fifteen to thirty minutes. The majority of these antibody self-testing kits use fast antigen testing, which involves taking a nose swab sample and analyzing it to look for proteins that are present on the virus surface. The sample will be coronavirus-positive if proteins are found in it. An extraction tube, a sterile nasal swab, and a testing card are included in antibody self-test kits. To gather a swab, one must scratch the back of their nose after inserting the swab stick into their nose 2-4 cm deep. You will get instantaneous outcomes quickly.

If people can get tested quickly and affordably and then immediately segregate themselves, an antibody self-test could revolutionize how the pandemic is managed in that country. According to public health experts, it would also shorten lines outside laboratories, lower expenses, and ease the strain on the existing workforce that is responsible for collecting samples from houses.

Semi-urban and rural areas with lower literacy rates have seen a lesser demand for these kits by Haled as compared to metro cities, which is mostly due to the difficulty of such exams for a first-time user. It has been claimed that in order to teach individuals how to do a self-test, demonstrations are required in the community.

[indizombie]

South Korea - that's so tiny - has 650 labs testing for the coronavirus, how many do we have?" asks Sujatha Rao, former federal health secretary. India has only 118 government laboratories and officials say 50 private labs will also be roped in. For a population of 1.3 billion, that is far from adequate. "India will have to identify many more labs, then the testing kits have to reach there, and technicians have to be trained. And getting the infrastructure ramped up will take time," Ms Rao says. You know the state of the healthcare facilities in the country? They are all bunched up in urban areas, there's very little facility in rural India. That will be a big challenge," she says.

Geeta Pandey, ‘Coronavirus: The woman behind India's first testing kit’, BBC

[breakingnewsworld]

Health Ministry cites study that says transmission could be restricted to 2.5 persons with safety norms.

[pathologylab]

[superpruchika99world]

IIT Kharagpur's low cost coronavirus testing method gets ICMR nod

Coronavirus A team of researchers at the Indian Institute of Technology in Kharagpur has developed a low-cost portable unit for rapid diagnostics of coronavirus, which produces results in under an hour.

The young researchers also claim that the testing facility, can be housed anywhere and an air-conditioned lab is not required. This new testing method implements a highly reliable and accurate molecular diagnostic procedure, conducted in an ultra-low-cost portable device unit and costs only around Rs. 500 per test.

ALSO READ: Pandemic speeding up automation; 85 million jobs are on the line: WEF

Each test requires a kit, three master-mixes which are made by the team. After several steps of mixing and heating, an image of the testing strips is grabbed by a smartphone camera of a custom-made mobile application, and a definite result is produced.

"COVIRAP has been vigorously tested and validated by the ICMR. Their test results have confirmed that the method and results are of highest standards and...Read more.

[kritikapatil]

Coronavirus Diagnostics Market to Scale New Heights as Market Players Focus on Innovations 2022 – 2027

Latest added Coronavirus Diagnostics Market research study by AMA Research offers detailed outlook and elaborates market review till 2027. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are

F. Hoffmann-La Roche AG (Switzerland)

Bio-Rad Laboratories Inc. (United States)

Beckman Coulter Inc. (United States)

Becton, Dickinson, and Company (United States)

Lonza Group AG (Switzerland)

Hologic, Inc. (United States)

QIAGEN (Germany)

GlaxoSmithKline Biologicals SA (Belgium)

Abbott Laboratories (United States)

Perkin Elmer, Inc. (United States)

Neuberg Diagnostics (India)

1drop Inc. (Switzerland)

Veredus Laboratories (Hong Kong)

ADT Biotech (Malaysia)

Quest Diagnostics (United States)

LabCorp (United States)

altona Diagnostics GmbH (Germany)

bioMérieux SA (France)

Mylab Discovery Solutions Pvt Ltd. (India)

Covid-19 is an infectious disease caused by a newly discovered coronavirus. The name Covid-19 represents the virus's membership of the coronavirus family, with its first human interaction noted in 2019. Coronavirus is the term coined for the family of viruses that are transmitted between animals and humans. Hence they are also known as zoonotic viruses. In addition, the virus outbreak was confirmed on March 27, 2020, on six continents and in more than 197 countries. According to the World Health Organization (WHO), fever, fatigue and dry cough are common symptoms of Covid-19 infection. Other symptoms of the disease include shortness of breath, sore throat, pain, and diarrhea in some cases, as well as nausea or a runny nose. In addition, this infection can spread from one person to another through droplets of saliva, or it can leak out of the nose when an infected person coughs or sneezes. The time from a person's exposure to Covid-19 to the onset of symptoms is generally between two and fourteen days, with an average of five days. The current status of lead COVID testing is toward increasing capacity but mixed accuracy. For efficient and accurate COVID-19 diagnosis, doctors need a portable or on-site diagnostic test to be able to manage patients in real-time in the shortest possible time. This has encouraged the introduction of point-of-care (POC) tests for diagnosis, the primary aim of which is to cut test times from hours to minutes. The most common concern of the governments of all nations affected by Covid-19 is the intolerable need to screen and test large numbers of patients for possible Sars-Cov-2 infections. As a result, most of them face significant bottlenecks in the supply of diagnostic kits to test for the virus. Diagnostic virology companies have been under immense pressure so as to provide reliable test kits and also the demand for the in vitro or point-of-care testing capabilities in the laboratories in various countries is also increasing. However, with the introduction of automated SARS-CoV-2 test systems, the diagnosis increases its capacity to carry out such tests considerably. However, currently, only a few companies are focused on developing rapid immunoassay tests for Covid-19 diagnosis.

Influencing Trend: A Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing

An Upsurge in Validating and Developing Rapid POC Immunodiagnostic Tests to Facilitate Decentralized Testing

Growing Trend of Incorporation of Artificial Intelligence (AI) in the COVID-19 Tests for Rapid and Efficient Diagnosis

Challenges: Shortage of Medical Professionals That Have Sufficient Knowledge Regarding the Use of Diagnostic Kits for COVID-19

Opportunities: Growth in Funding For Research on Coronavirus Diagnostics

Increasing Application of Molecular Diagnostic Technologies in Pharmacogenetics and Point-Of-Care Testing

The Rise in Integration of Novel Technologies and Software Solutions with COVID-19 Testing

Market Growth Drivers: The Increasing Global Prevalence of COVID-19

Unavailability of Specific Medicine or a Vaccine for the Coronavirus Disease

An Increase in the Need for Developing Diagnostic Tests Owing to the Global Conditions

The Increased Demand for Rapid Immunoassay Tests for Disease Diagnosis

The Global Coronavirus Diagnostics segments and Market Data Break Down by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-CoV), End-Users (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Diagnostic Centers and Clinics, Research Institutes, Others), Sample Type (Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab), Mode of Diagnosis (Point-of-Care (POC), Non-Point-of-Care (Non-PoC))

Presented By

AMA Research & Media LLP

[gujarati9-blog]

आईआईटी दिल्ली ने विकसित की दुनिया की सबसे सस्ती कोरोना किट, 399 रुपए वाली किट का नाम रखा ‘कोरोश्योर’ Hindi NewsHappylifeIIT Delhi Develops World's Cheapest Corona Kit, Rs 399 Kit Named 'Corrosure' 3 महीने पहले

[telugurajyam]

కరోనా టెస్టు‌లకు ‘ఫెలుడా’.. ఇది భలే చౌక, ఎలా పనిచేస్తుందంటే..

[ad_1]

కరోనా వైరస్ ఎంతగా విస్తరించిందో తెలిసిందే. రోజు రోజుకు పెరుగుతున్న కరోనా రోగుల సంఖ్య వల్ల టెస్టులు కూడా పెరిగాయి. ఈ నేపథ్యంలో మన దేశానికి చెందిన టాటా సంస్థ కోవిడ్ టెస్ట్ కిట్‌ను రూపొందించింది. CSIR – IGIB (ఇన్‌స్టిట్యూట్‌ ఆఫ్‌ జీనోమిక్స్‌ అండ్‌ ఇంటిగ్రేటివ్‌ బయాలజీ) అభివృద్ధి చేసిన సీఆర్‌ఐఎస్‌పీఆర్‌ అనే టెక్నాలజీ ఆధారంగా ఈ టెస్ట్ కిట్ పనిచేస్తుంది. ప్రస్తుతం కరోనా టెస్టులకు వాడుతున్న…